DOXERCALCIFEROL
Generic: DOXERCALCIFEROL
Gland Pharma LimitedManufacturer
INTRAVENOUSRoute
DOXERCALCIFEROLActive Substance
2019-09-26Original Approval
DOXERCALCIFEROL is FDA application ANDA210452, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
13 reports
2
ACUTE KIDNEY INJURY
12 reports
3
FATIGUE
12 reports
4
RENAL FAILURE
12 reports
5
END STAGE RENAL DISEASE
11 reports
6
VOMITING
11 reports
7
CHRONIC KIDNEY DISEASE
10 reports
8
DRUG HYPERSENSITIVITY
10 reports
9
NAUSEA
9 reports
10
PAIN
9 reports